In hamsters the D1 receptor antagonist SCH23390 depresses ventilation during hypoxia

被引:11
|
作者
Schlenker, Evelyn H. [1 ]
机构
[1] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA
关键词
hamster; dopamine D-1 receptor; hypoxia; hypercapnia; body temperature;
D O I
10.1016/j.brainres.2007.10.058
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
During exposure of animals to hypoxia, brain and blood dopamine levels increase stimulating dopaminergic receptors which influence the integrated ventilatory response to low oxygen. The purpose of the present study is to test the hypothesis that in conscious hamsters, systemic antagonism of D-1 receptors would depress their breathing in air and in response to hypoxic and hypercapnic challenges. Nine male hamsters were treated with saline or 0.25 mg/kg SCH-23390 (SCH), a D-1 receptor antagonist that crosses the blood-brain barrier. Ventilation was determined using the barometric method, and oxygen consumption and CO2 production were evaluated utilizing the flow-through method. During exposure to air, SCH decreased frequency of breathing. During exposure to hypoxia (10% oxygen in nitrogen), relative to saline, SCH-treated hamsters decreased minute ventilation by decreasing tidal volume and oxygen consumption but not CO2 production. During exposure to hypercapnia (5% CO2 in 95% O-2), frequency of breathing was decreased with SCH, but there was no significant effect on minute ventilation. Relative to saline treatment body temperature was lower in SCH-treated hamsters by 0.6 degrees C. These results demonstrate that in hamsters D-1 receptors can modulate control of ventilation in air and during hypoxia. and hypercapnic exposures. Whether D-1 receptors located centrally or on carotid bodies modulate these effects is not clear from this study. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 50 条
  • [21] EFFECTS OF SCH23390, D1 RECEPTOR ANTAGONIST, MICROINJECTED INTO NUCLEUS ACCUMBENS-SHELL ON ETHANOL-SEEKING IN ALCOHOL-PREFERRING (P) RATS
    Hauser, S. R.
    McBride, W. J.
    Rodd, Z. A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 38A - 38A
  • [22] Reversal of dizocilpine-induced blockade of cocaine sensitisation by D1 dopamine receptor antagonist SCH 23390
    Parada, A
    Soares-da-Silva, P
    FASEB JOURNAL, 2000, 14 (04): : A387 - A387
  • [23] THE D1 DOPAMINE RECEPTOR ANTAGONIST SCH-23390 INCREASES COCAINE SELF-ADMINISTRATION IN THE RAT
    KOOB, GF
    LE, HT
    CREESE, I
    NEUROSCIENCE LETTERS, 1987, 79 (03) : 315 - 320
  • [24] Effect of the dopamine D1/5 antagonist SCH 23390 on the acquisition of conditioned fear
    Inoue, T
    Izumi, T
    Maki, Y
    Muraki, I
    Koyama, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 66 (03) : 573 - 578
  • [25] SLEEP DURING ACUTE DOPAMINE D1 AGONIST SKF-38393 OR D1 ANTAGONIST SCH-23390 ADMINISTRATION IN RATS
    MONTI, JM
    FERNANDEZ, M
    JANTOS, H
    NEUROPSYCHOPHARMACOLOGY, 1990, 3 (03) : 153 - 162
  • [26] In Vivo DA D1 Receptor Selectivity of NNC 112 and SCH 23390
    Jesper Ekelund
    Mark Slifstein
    Raj Narendran
    Olivier Guillin
    Hemant Belani
    Ning-Ning Guo
    Yuying Hwang
    Dah-Ren Hwang
    Anissa Abi-Dargham
    Marc Laruelle
    Molecular Imaging and Biology, 2007, 9
  • [27] Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain:: Potential interaction with A2A and D2-like receptors
    Leonard, Sarah K.
    Ferry-Leeper, Penelope
    Mailman, Richard B.
    BRAIN RESEARCH, 2006, 1117 : 25 - 37
  • [28] Dopamine D1 receptor availability in Gilles de la Tourette syndrome measured by [11C]SCH23390 PET
    Rullmann, M.
    Gkotsoulias, D.
    Schmitt, S.
    Fremer, C.
    Klages, C.
    Hartung, K.
    Bujanow, A.
    Zientek, F.
    Messerschmidt, K.
    Patt, M.
    Sabri, O.
    Mueller-Vahl, K.
    Moeller, H.
    Barthel, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S244 - S244
  • [29] In vivo DA D1 receptor selectivity of NNC 112 and SCH 23390
    Ekelund, Jesper
    Slifstein, Mark
    Narendran, Raj
    Guillin, Olivier
    Belani, Hemant
    Guo, Ning-Ning
    Hwang, Yuying
    Hwang, Dah-Ren
    Abi-Dargham, Anissa
    Laruelle, Marc
    MOLECULAR IMAGING AND BIOLOGY, 2007, 9 (03) : 117 - 125
  • [30] SELECTIVE D2 DOPAMINE RECEPTOR AGONISTS PREVENT CATALEPSY INDUCED BY SCH 23390, A SELECTIVE D1 ANTAGONIST
    MELLER, E
    KUGA, S
    FRIEDHOFF, AJ
    GOLDSTEIN, M
    LIFE SCIENCES, 1985, 36 (19) : 1857 - 1864